Thrombosis Journal

Article	Citations
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow	58
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report	41
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE	35
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?	33
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe	32
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	25
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study	24
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome	22
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	22
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	21
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis	20
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes	20
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia	20
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	20
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	19
Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients	19
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India	18
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens	16
Comparison between canine and porcine models of chronic deep venous thrombosis	16
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study	16
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study	15
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	15
Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer	15
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia	15
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance	15

Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial	14
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	14
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis	13
The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis	13
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on	13
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study	12
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study	12
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis	12
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	12
Association between obstructive sleep apnea and venous thromboembolism recurrence: results from a French cohort	12
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults	12
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant	12
Structure, signal transduction, activation, and inhibition of integrin αIIbβ3	12
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism	12
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban	11
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods	11
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	11
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI	11
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report	11
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection	11
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o	11
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency	11
Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume	10
Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study	10
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study	10
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)	10
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation	10
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage	10
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia	9
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy	9
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism	9
Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia	9
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article	9
Correction: Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	9
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis	9
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage	9
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review	9
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism	9
Causes of death after first time venous thromboembolism	8
NETosis and SARS-COV-2 infection related thrombosis: a narrative review	8
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy	8
Morphologic change in deep venous thrombosis in the lower extremity after therapeutic anticoagulation	8
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery	8
Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation	8
Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study	8
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19	8
Practical approach to thrombocytopenia in patients with sepsis: a narrative review	8
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab	7
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association	7
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene	7

Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	7
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	7
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database	7
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	7
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review	7
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization	7
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study	7
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis	7
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study	7
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis	7
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	7
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	7
Predictors of pulmonary embolism in hospitalized patients with COVID-19	7
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study	7
Venous thromboembolic disease in admitted blunt trauma patients: what matters?	7
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion	6
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome	6
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re	6
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study	6
“Y appearance” infarction: caused by essential thrombocythemia	6
The effect of neutrophil extracellular traps in venous thrombosis	6
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases	6
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study	6
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study	6
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic	6
Lemierre’s syndrome complicating deep neck abscess: a case report	6
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study	6
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19	6
Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM®: a prospective observational study	6
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study	5
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study	5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study	5
Clinical characteristics of COVID-19 associated vasculopathic diseases	5
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	5
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia	5
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study	5
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model	5
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database	5
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study	5
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks	5
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden	5
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry	5
Risk factors for thrombolysis-related intracranial hemorrhage: a systematic review and meta-analysis	5
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4	5
Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana	5
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study	5
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing	5
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	5
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro	5
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial	5
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study	5
Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging	4
Robust preimplantation genetic testing of the common F8 Inv22 pathogenic variant of severe hemophilia A using a highly polymorphic multi-marker panel encompassing the paracentric inversion	4
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma	4
Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China	4
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study	4
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery	4
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study	4
Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study	4
Association of initial national early warning score with clinical deterioration in pulmonary embolism	4
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study	4
Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction	4
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE	4
Right heart thrombus in transit and peripherally inserted central catheters	4
An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature	4
Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) associated with gastric carcinoma: a case report	4
Neutrophil levels upon admission for the assessment of acute pulmonary embolism with intermediate- and high-risk: an indicator of thrombosis and inflammation	4
Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study	4
Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review	4
Establishment and validation of a predictive model for lower extremity deep vein thrombosis in patients with traumatic pelvic fractures	4
Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis	4
Multiple venous thromboembolisms in a pregnant patient carrying a novel mutation in SERPINC1 (p.M313T) that causes a transient antithrombin deficiency: a case report	4
Correction to: Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer	4
Tranexamic acid for haemostasis and beyond: does dose matter?	4
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19	4
Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study	4
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism	4
Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study	4

Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	3
Identification of two point mutations associated with inherited antithrombin deficiency	3
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysis	3
D-dimer to fibrinogen ratio as a marker for acute cerebral venous thrombosis	3
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis	3
Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases	3
Narsoplimab for severe transplant-associated thrombotic microangiopathy	3
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)	3
Patient self-management of warfarin therapy – a long-term follow up study	3
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study	3
Inflammatory biomarkers may be associated with poor outcomes after mechanical thrombectomy	3
Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review	3
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study	3
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials	3
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report	3
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis	3
Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update	3
Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis	3
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview	3
Progress in the clinical effects and adverse reactions of ticagrelor	3
Letter to editor: Impact of extracorporeal membrane oxygenation treatments on acquired von willebrand syndrome in patients with out of-hospital cardiac arrest: a retrospective observational study	3
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia	3
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand	3
A mendelian randomization study on the association between 731 types of immune cells and 91 types of blood cells with venous thromboembolism	3
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation	3
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients	3
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country	3
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients	3
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China	3
A prediction model for left ventricular thrombus persistence/recurrence: based on a prospective study and a retrospective study	2
Cancer-associated venous thromboembolism: a comprehensive review	2
Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	2
Spontaneous coronary artery dissection in a young patient with antiphospholipid syndrome	2
A prediction nomogram for deep venous thrombosis risk in patients undergoing primary total hip and knee arthroplasty: a retrospective study	2
Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysis	2
Deep vein thrombosis in severe community-acquired pneumonia patients undergoing thromboprophylaxis: Prevalence, risk factors, and outcome	2
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse	2
Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study	2
High incidence of undiagnosed deep vein thrombosis among hospitalized people living with HIV: a cross-sectional study	2
A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score	2
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis	2
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to action	2
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu’s arteritis: a case report and review of the literature	2
Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis	2
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study	2
Characterization of spreading depolarizations in swine following superior sagittal sinus occlusion: a novel gyrencephalic model study	2
Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg	2
Factors influencing DVT formation in sepsis	2
Predictive value of magnetic resonance angiography combined with serum ischemia-modified albumin for secondary cerebral infarction after transient ischemic attack	2
Risk factors for venous thromboembolism in a single pediatric intensive care unit in China	2
Impact of extracorporeal membrane oxygenation treatments on acquired von Willebrand syndrome in patients with out-of-hospital cardiac arrest: a retrospective observational study	2
Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus- a meta-analysis update	2
Clinical characteristics of venous thromboembolism onset from severe high altitude pulmonary edema in plateau regions	2
Endoplasmic reticulum protein 29 negatively regulates platelet functions and thrombosis in mice	2
Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism	2
Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study	2
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review	2
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer	2
Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis	2
D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention	2
Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies	2
Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study	2
Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis	2
Soluble P-selectin and correlation with Prothrombin Fragment 1 + 2 in myeloid malignancies in Cipto Mangunkusumo general hospital	2
Successful retrieval of tip-embedded inferior vena cava filter using a modified forceps technique: case report	2
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background	2
Risk factors for central venous catheter-associated deep venous thrombosis in pediatric critical care settings identified by fusion model	2
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation	2
The role of controlling nutritional status score in predicting postthrombotic syndrome in patients with lower extremity deep venous thrombosis	2
Factors associated with bleeding events during catheter ablation with uninterrupted periprocedural edoxaban for atrial fibrillation: a subanalysis of the KYU-RABLE study	2
Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis	2